BR9708248A - Benzotiofenos formulações contendo os mesmos e metódos - Google Patents

Benzotiofenos formulações contendo os mesmos e metódos

Info

Publication number: BR9708248A
Authority: BR; Brazil
Prior art keywords: methods; same; formulations containing; benzothiophene; benzothiophene formulations
Prior art date: 1996-03-26

Application number

BR9708248A

Other languages

English (en)

Inventor

Gordon N Arbuthnot

Brian W Dalder

Kerry J Hartauer

Wayne D Luke

Robert E Schutzki

Original Assignee

Lilly Co Eli

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-03-26

Filing date

1997-03-20

Publication date

1999-07-27

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26309061&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR9708248(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1996-04-04 Priority claimed from GBGB9607110.5A external-priority patent/GB9607110D0/en

1997-03-20 Application filed by Lilly Co Eli filed Critical Lilly Co Eli

1999-07-27 Publication of BR9708248A publication Critical patent/BR9708248A/pt

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D333/56—Radicals substituted by oxygen atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Physical Education & Sports Medicine (AREA)
Reproductive Health (AREA)
Endocrinology (AREA)
Diabetes (AREA)
Orthopedic Medicine & Surgery (AREA)
Obesity (AREA)
Hematology (AREA)
Rheumatology (AREA)
Gynecology & Obstetrics (AREA)
Pregnancy & Childbirth (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Thin Film Transistor (AREA)

BR9708248A 1996-03-26 1997-03-20 Benzotiofenos formulações contendo os mesmos e metódos BR9708248A (pt)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US1416796P	1996-03-26	1996-03-26
GBGB9607110.5A GB9607110D0 (en)	1996-04-04	1996-04-04	Benzothiopenes formulations containing same and methods
PCT/US1997/004259 WO1997035571A1 (en)	1996-03-26	1997-03-20	Benzothiophenes, formulations containing same, and methods

Publications (1)

Publication Number	Publication Date
BR9708248A true BR9708248A (pt)	1999-07-27

Family

ID=26309061

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BR9708248A BR9708248A (pt)	1996-03-26	1997-03-20	Benzotiofenos formulações contendo os mesmos e metódos

Country Status (29)

Country	Link
EP (2)	EP0910369B1 (pt)
JP (5)	JP2000507268A (pt)
CN (1)	CN1162153C (pt)
AR (1)	AR006387A1 (pt)
AT (1)	ATE464897T1 (pt)
AU (1)	AU723797B2 (pt)
BR (1)	BR9708248A (pt)
CA (1)	CA2250191C (pt)
CO (1)	CO4780022A1 (pt)
CZ (1)	CZ300341B6 (pt)
DE (1)	DE69739855D1 (pt)
DK (1)	DK0910369T3 (pt)
EA (1)	EA001257B1 (pt)
ES (1)	ES2341399T3 (pt)
ID (1)	ID19813A (pt)
IL (2)	IL126320A (pt)
ME (2)	MEP18308A (pt)
MY (1)	MY115533A (pt)
NO (1)	NO320894B1 (pt)
NZ (1)	NZ332036A (pt)
PL (1)	PL191148B1 (pt)
PT (1)	PT910369E (pt)
RO (1)	RO121117B1 (pt)
SI (1)	SI0910369T1 (pt)
TR (1)	TR199801915T2 (pt)
TW (1)	TW513421B (pt)
UA (1)	UA57596C2 (pt)
WO (1)	WO1997035571A1 (pt)
YU (1)	YU41898A (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU723797B2 (en) *	1996-03-26	2000-09-07	Eli Lilly And Company	Benzothiophenes, formulations containing same, and methods
IL122025A (en) *	1996-10-30	2003-01-12	Lilly Co Eli	Use of raloxifene or pharmaceutically acceptable salts or solvates thereof, in the preparation of a medicament for preventing breast cancer
ZA979723B (en)	1996-10-30	1999-07-29	Lilly Co Eli	Methods of preventing breast cancer.
AU2003266940B2 (en)	2002-09-30	2007-02-08	A/S Gea Farmaceutisk Fabrik	Novel raloxifene acid addition salts and/or solvates thereof, improved method for purification of said raloxifene acid addition salts and/or solvates thereof and pharmaceutical compositions comprising these
WO2008047105A1 (en)	2006-10-17	2008-04-24	Cipla Limited	Crystalline form of benzothiophene compound and process for preparation thereof
WO2009080364A1 (en) *	2007-12-21	2009-07-02	Synthon B.V.	Raloxifene composition
ES2683012T3 (es) *	2008-04-15	2018-09-24	Nippon Chemiphar Co., Ltd.	Agente activador para el receptor activado por proliferadores de peroxisomas
DK3202420T3 (da) *	2008-12-11	2020-04-06	Besins Healthcare Lu Sarl	Transdermale farmaceutiske sammensætninger omfattende en serm
EP2448562B1 (en)	2009-07-02	2013-11-06	Synthon B.V.	Raloxifene composition
WO2011099942A1 (en)	2010-02-09	2011-08-18	Silverstone Pharma	New addition salts of raloxifene, process for the preparation thereof and use thereof in therapy
GB201515387D0 (en) *	2015-08-28	2015-10-14	Amazentis Sa	Compositions
GB201515391D0 (en) *	2015-08-28	2015-10-14	Amazentis Sa	Compositions
PL3251661T3 (pl)	2016-05-30	2021-06-14	Sun Pharmaceutical Industries Limited	Kompozycja raloksyfenu do posypywania

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4133814A (en) *	1975-10-28	1979-01-09	Eli Lilly And Company	2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents
US4418068A (en) *	1981-04-03	1983-11-29	Eli Lilly And Company	Antiestrogenic and antiandrugenic benzothiophenes
US4380635A (en)	1981-04-03	1983-04-19	Eli Lilly And Company	Synthesis of acylated benzothiophenes
JPS63112519A (ja) *	1986-10-28	1988-05-17	Shin Etsu Chem Co Ltd	ニフエジピン製剤の製造方法
NL9000634A (nl) *	1990-03-20	1991-10-16	Catharina Ziekenhuis Stichting	Suspensie-injectiepreparaat op waterbasis, werkwijze voor de bereiding daarvan en toepassing van dit preparaat voor pijnbestrijding.
TW366342B (en) *	1992-07-28	1999-08-11	Lilly Co Eli	The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss
DE69322764T2 (de) *	1992-10-09	1999-05-06	Kanegafuchi Kagaku Kogyo K.K., Osaka	Herstellungsmethode für feines granulat
US5482949A (en) *	1993-03-19	1996-01-09	Eli Lilly And Company	Sulfonate derivatives of 3-aroylbenzo[b]thiophenes
US5482950A (en) *	1993-10-15	1996-01-09	Eli Lilly And Company	Methods for lowering serum cholesterol
CA2176130A1 (en) *	1993-12-21	1995-06-29	Thomas Alan Crowell	Non-peptide tachykinin receptor antagonists
IL112746A (en) *	1994-03-02	1999-12-31	Lilly Co Eli	Orally administrable pharmaceutical formulation comprising raloxifene hydrochoride
US5478847A (en) *	1994-03-02	1995-12-26	Eli Lilly And Company	Methods of use for inhibiting bone loss and lowering serum cholesterol
US5567820A (en) *	1994-05-20	1996-10-22	Eli Lilly And Company	Glucopyranoside benzothiophenes
US5494920A (en) *	1994-08-22	1996-02-27	Eli Lilly And Company	Methods of inhibiting viral replication
CO4410190A1 (es) *	1994-09-19	1997-01-09	Lilly Co Eli	3-[4-(2-AMINOETOXI)-BENZOIL]-2-ARIL-6-HIDROXIBENZO [b] TIOFENO CRISTALINO
US5494929A (en)	1995-01-12	1996-02-27	Eli Lilly And Company	Methods of inhibiting growth hormone effects
US5532254A (en)	1995-06-07	1996-07-02	Eli Lilly And Company	Modulation of calcium channels using benzothiophenes
AU723797B2 (en) *	1996-03-26	2000-09-07	Eli Lilly And Company	Benzothiophenes, formulations containing same, and methods

1997
- 1997-03-20 AU AU22154/97A patent/AU723797B2/en not_active Expired
- 1997-03-20 SI SI9730794T patent/SI0910369T1/sl unknown
- 1997-03-20 EA EA199800865A patent/EA001257B1/ru not_active IP Right Cessation
- 1997-03-20 PL PL329051A patent/PL191148B1/pl unknown
- 1997-03-20 CN CNB971932492A patent/CN1162153C/zh not_active Expired - Lifetime
- 1997-03-20 UA UA98095028A patent/UA57596C2/uk unknown
- 1997-03-20 CA CA002250191A patent/CA2250191C/en not_active Expired - Fee Related
- 1997-03-20 PT PT97915139T patent/PT910369E/pt unknown
- 1997-03-20 EP EP97915139A patent/EP0910369B1/en not_active Revoked
- 1997-03-20 TR TR1998/01915T patent/TR199801915T2/xx unknown
- 1997-03-20 EP EP09165873A patent/EP2266560A1/en not_active Withdrawn
- 1997-03-20 DK DK97915139.6T patent/DK0910369T3/da active
- 1997-03-20 NZ NZ332036A patent/NZ332036A/en not_active IP Right Cessation
- 1997-03-20 IL IL12632097A patent/IL126320A/en not_active IP Right Cessation
- 1997-03-20 AT AT97915139T patent/ATE464897T1/de active
- 1997-03-20 WO PCT/US1997/004259 patent/WO1997035571A1/en not_active Application Discontinuation
- 1997-03-20 ME MEP-183/08A patent/MEP18308A/xx unknown
- 1997-03-20 ME MEP-2008-183A patent/ME00074B/me unknown
- 1997-03-20 RO RO98-01419A patent/RO121117B1/ro unknown
- 1997-03-20 JP JP9534467A patent/JP2000507268A/ja not_active Withdrawn
- 1997-03-20 ES ES97915139T patent/ES2341399T3/es not_active Expired - Lifetime
- 1997-03-20 IL IL140742A patent/IL140742A/en not_active IP Right Cessation
- 1997-03-20 DE DE69739855T patent/DE69739855D1/de not_active Expired - Lifetime
- 1997-03-20 CZ CZ0305398A patent/CZ300341B6/cs not_active IP Right Cessation
- 1997-03-20 BR BR9708248A patent/BR9708248A/pt active IP Right Grant
- 1997-03-21 CO CO97015459A patent/CO4780022A1/es unknown
- 1997-03-24 ID IDP970956A patent/ID19813A/id unknown
- 1997-03-24 MY MYPI97001237A patent/MY115533A/en unknown
- 1997-03-25 AR ARP970101196A patent/AR006387A1/es not_active Application Discontinuation
- 1997-03-26 TW TW086103861A patent/TW513421B/zh not_active IP Right Cessation
1998
- 1998-09-24 NO NO19984444A patent/NO320894B1/no not_active IP Right Cessation
- 1998-09-25 YU YU41898A patent/YU41898A/sh unknown
2008
- 2008-09-04 JP JP2008227311A patent/JP2009019057A/ja not_active Withdrawn
2013
- 2013-06-04 JP JP2013118034A patent/JP2013166797A/ja not_active Withdrawn
2015
- 2015-06-09 JP JP2015116526A patent/JP6095725B2/ja not_active Expired - Lifetime
2016
- 2016-03-23 JP JP2016059108A patent/JP6095821B2/ja not_active Expired - Lifetime

Also Published As

Publication number	Publication date
DK0910369T3 (da)	2010-07-26
MY115533A (en)	2003-07-31
AR006387A1 (es)	1999-08-25
CZ300341B6 (cs)	2009-04-22
ME00074B (me)	2010-10-10
JP2013166797A (ja)	2013-08-29
EA001257B1 (ru)	2000-12-25
JP2009019057A (ja)	2009-01-29
NO984444L (no)	1998-11-26
TW513421B (en)	2002-12-11
EP2266560A1 (en)	2010-12-29
EP0910369A4 (en)	2001-03-21
ID19813A (id)	1998-08-06
CA2250191A1 (en)	1997-10-02
CN1162153C (zh)	2004-08-18
IL126320A0 (en)	1999-05-09
IL126320A (en)	2001-08-08
ES2341399T3 (es)	2010-06-18
NO320894B1 (no)	2006-02-06
RO121117B1 (ro)	2006-12-29
PL191148B1 (pl)	2006-03-31
PT910369E (pt)	2010-06-04
EA199800865A1 (ru)	1999-02-25
IL140742A0 (en)	2002-02-10
JP2000507268A (ja)	2000-06-13
NZ332036A (en)	1999-04-29
ATE464897T1 (de)	2010-05-15
JP2016106159A (ja)	2016-06-16
JP6095821B2 (ja)	2017-03-15
IL140742A (en)	2012-02-29
JP2015157865A (ja)	2015-09-03
DE69739855D1 (de)	2010-06-02
SI0910369T1 (sl)	2010-08-31
CA2250191C (en)	2005-11-15
AU723797B2 (en)	2000-09-07
PL329051A1 (en)	1999-03-01
AU2215497A (en)	1997-10-17
CN1213967A (zh)	1999-04-14
NO984444D0 (no)	1998-09-24
CZ305398A3 (cs)	1999-05-12
JP6095725B2 (ja)	2017-03-15
UA57596C2 (uk)	2003-06-16
MEP18308A (en)	2010-06-10
YU41898A (sh)	1999-07-28
TR199801915T2 (xx)	1998-12-21
WO1997035571A1 (en)	1997-10-02
EP0910369A1 (en)	1999-04-28
HK1020671A1 (en)	2000-05-19
EP0910369B1 (en)	2010-04-21
CO4780022A1 (es)	1999-05-26

Publication	Publication Date	Title
DE69714227D1 (de)	2002-08-29	Abseilgerät
DE69726189D1 (de)	2003-12-18	Mikrokeratom
NO985460D0 (no)	1998-11-23	Limsammensetning
ID18090A (id)	1998-02-26	Mikrokapsul menggunakan iminooksadiazinadiona poliisosianat
IT1292304B1 (it)	1999-01-29	Bastoncino cosmetico
BR9708248A (pt)	1999-07-27	Benzotiofenos formulações contendo os mesmos e metódos
ATE353652T1 (de)	2007-03-15	Östroprogestatives antikonzeptionsmittel
BR9707657A (pt)	1999-07-27	Benzotiofenos formulações contendo os mesmos e métodos
KR980000769U (ko)	1998-03-30	병상
NO985084D0 (no)	1998-11-02	Vial
NL1007839A1 (nl)	1998-06-23	Formulering en gebruik.
FI956301L (fi)	1995-12-28	Suksi
DE59708546D1 (de)	2002-11-28	Löschgerät
NO983506D0 (no)	1998-07-30	Mellomkobling
KR970007831U (ko)	1997-03-27	김밥 말이용 김발
KR970060741U (ko)	1997-12-10	압봉
ITBO960020A0 (it)	1996-01-19	Aeroporto sopraelevato
KR970049895U (ko)	1997-08-12	글로브발브의 플러그
FI103716B1 (fi)	1999-08-31	Salibandymaila
KR970048842U (ko)	1997-08-12	화장품 케이스
KR980000895U (ko)	1998-03-30	게이트볼 스틱
ES1035478Y (es)	1997-12-01	Palito mejorado
KR980000403U (ko)	1998-03-30	립스틱
KR970053290U (ko)	1997-10-13	립스틱
KR970060435U (ko)	1997-12-10	립스틱

Legal Events

Date	Code	Title	Description
2003-03-18	FB36	Technical and formal requirements: requirement - article 36 of industrial property law
2003-05-06	HJEG	Technical examination (opinion): technical examination (opinion) related to article 229 of industrial property law
2004-03-02	FF	Decision: intention to grant
2004-05-25	B16A	Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]
2004-12-21	B17A	Notification of administrative nullity (patentee has 60 days time to reply to this notification)	Free format text: HENRY JUN SUZUKI
2012-09-25	B22O	Other matters related to patents and certificates of addition of invention: legal action concerning patent	Free format text: INPI-52400.060956/2012-01 ORIGEM: JUIZO DA 009A VARA FEDERAL DO RIO DE JANEIRO PROCESSO NO0033961-40.2012.4.02.5101 ACAO ORDINARIA DE NULIDADE DA PATENTE AUTOR: ASSOCIACAO BRASILEIRA DAS INDUSTRIAS DE MEDICAMENTOS GENERICOS - PRO GENERICOS REU: ELY LILLY AND COMPANY E INSTITUTO NACIONAL DA PROPRIEDADE INDUSTRIAL - INPI.
2020-04-14	B19A	Notification of judicial decision: notification of judicial decision	Free format text: INPI NO 52400.060956/2012-01 VARA: 09A VFJ PROCESSO : 0033961-40.201924.02.5101 - NUP: 00848.000232/2020-58 APELANTE: ASSOCIACAO BRASILEIRA DAS INDUSTRIAS DE MEDICAMENTOS GENERICOS- PRO GENERICOS APELADO : ELY LILLY AND COMPANY E INSTITUTO NACIONAL DA PROPRIEDADE INDUSTRIAL ? INPI DECISAO: DOU PROVIMENTO AS APELACOES, PARA JULGAR PROCEDENTE O PEDIDO E DECLARAR A NULIDADE DA PATENTE DE INVENCAO PI9708248-1. TRANSITO EM JULGADO.
2020-04-22	B16D	Grant of patent or certificate of addition of invention cancelled	Free format text: ANULADA A PUBLICACAO CODIGO 16.1 NA RPI NO 1742 DE 25/05/2004 POR TER SIDO INDEVIDA.CONFORME DETERMINACAO JUDICIAL - PROCESSO INPI NO 52400.060956/2012-01